Kutlesic Ranko, Kutlesic Marija, Milosevic-Stevanovic Jelena, Vukomanovic Predrag, Stefanovic Milan, Mostic-Stanisic Danka
Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Nis, 18000 Nis, Serbia.
Clinic of Gynaecology and Obstetrics, University Clinical Centre Nis, 18000 Nis, Serbia.
J Clin Med. 2024 Oct 1;13(19):5868. doi: 10.3390/jcm13195868.
Endometriosis and hyperprolactinaemia are conditions that might lead to infertility as a consequence. The aim of this article was to present the current knowledge about possible relationships between prolactin/hyperprolactinaemia and endometriosis-related infertility. Experimental studies on local prolactin acting as cytokine and relationship of prolactin and endometriotic tissue, as well as clinical studies on hyperprolactinaemia and endometriosis-related infertility suggest the possible role of prolactin in endometriosis-related infertility, but final proof is still missing and the exact pathogenesis of infertility in such cases is still under investigation. Novel strategies in the treatment of endometriosis-related infertility, based on its connection with prolactin such as the use of prolactin receptor antibodies and prolactin receptor antagonists, are under investigation, but adequate clinical studies have yet to be undertaken.
子宫内膜异位症和高催乳素血症是可能导致不孕的病症。本文的目的是介绍目前有关催乳素/高催乳素血症与子宫内膜异位症相关不孕之间可能关系的知识。关于局部催乳素作为细胞因子的实验研究以及催乳素与子宫内膜异位组织的关系,以及关于高催乳素血症和子宫内膜异位症相关不孕的临床研究表明,催乳素在子宫内膜异位症相关不孕中可能起作用,但仍缺乏最终证据,此类病例中不孕的确切发病机制仍在研究中。基于其与催乳素的联系,如使用催乳素受体抗体和催乳素受体拮抗剂等治疗子宫内膜异位症相关不孕的新策略正在研究中,但尚未进行充分的临床研究。